The Safety and Efficacy of Fufangdanshen Tablets in Treatment of Mild to Moderate Vascular Dementia: a 24-week, Double Blind, Randomized, Parallel,Placebo Controlled Trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ginsenoside Rb1/ginsenoside-Rg1/notoginsenoside-R1/salvianolic-acid-B/tanshinone-IIA (Primary)
- Indications Vascular dementia
- Focus Therapeutic Use
- 23 Oct 2018 Biomarkers information updated
- 23 Jan 2013 New trial record